Inventor profile of:

Branimir Sikic

City:

Stanford, California

Country:

United States

Published Applications:

12

Last publication date:

2007-06-28

Top Assignees for applications by Branimir Sikic

The entities that hold a legal rights for patent applications filed by inventor Sikic Branimir:

Recent patent applications by Sikic Branimir

Branimir Sikic from Stanford, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2007-06-28
US20070148145A1
Chemistry; metallurgy

Protein modulators of resistance to alkylating agents

#2 | 2007-01-11
US20070010487A1
Human necessities

Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins

#3 | 2007-01-11
US20070010486A1
Human necessities

Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins

#4 | 2007-01-11
US20070010485A1
Human necessities

Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins

#5 | 2007-01-11
US20070010478A1
Human necessities

Zosuquidar, daunorubicin, and cytarabine for the treatment of cancer

#6 | 2007-01-11
US20070010466A1
Human necessities

Zosuquidar, daunorubicin, and cytarabine for the treatment of cancer

#7 | 2007-01-11
US20070010465A1
Human necessities

Zosuquidar, daunorubicin, and cytarabine for the treatment of cancer

#8 | 2007-01-11
US20070009535A1
Physics

Treatment of cancer patients exhibiting activation of the P-glycoprotein efflux pump mechanism

#9 | 2007-01-11
US20070009534A1
Human necessities

Treatment of cancer patients exhibiting activation of the P-glycoprotein efflux pump mechanism

#10 | 2007-01-11
US20070009533A1
Human necessities

Treatment of cancer patients exhibiting activation of the P-glycoprotein efflux pump mechanism

#11 | 2007-01-11
US20070009532A1
Human necessities

Treatment of patients with cancer using a calicheamicin-antibody conjugate in combination with zosuquidar

#12 | 2007-01-11
US20070009531A1
Human necessities

Treatment of patients with cancer using a calicheamicin-antibody conjugate in combination with zosuquidar

InventorID:

4333335 ⎘